Sarcopénie en oncologie digestive : critères diagnostiques, implications cliniques et prise en charge
Bulletin du Cancer · 2026-11 · 113 (11) · 1278-1292
DOI: 10.1016/j.bulcan.2026.06.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bulletin du Cancer, 2026-11. Verfasst von Géraldine M Camilleri und 10 weiteren Autor:innen. Beteiligte Einrichtung: Département de médecine, service d'oncologie digestive, Gustave-Roussy, 114, rue Édouard-Vaillant, 94800 Villejuif, France. Electronic address: geral…. Hauptthemen laut MEDLINE: Sarcopenia, Gastrointestinal Neoplasms. Die Arbeit nennt 84 Literaturangaben.
Abstract (Originalsprache)
Sarcopenia is defined as a loss of muscle mass and strength. It represents a frequent and multifactorial complication in patients with gastrointestinal cancers, resulting from the combined effects of malnutrition, chronic inflammation, metabolic alterations, and reduced physical activity level. Its assessment relies on a combined approach integrating imaging tools and functional tests. Computed tomography, widely available in oncology, represents the reference method for the evaluation of body composition, particularly skeletal muscle mass and quality. Functional tests allow assessment of muscle strength and physical performance. Sarcopenia, including sarcopenic obesity phenotype, has a major prognostic impact from localized disease to advanced stages, being associated with an increased risk of postoperative complications, reduced tolerance to anticancer treatments, and decreased survival. Its management should be early, personalized, and multimodal, combining nutritional support, adapted physical activity, and a global patient-centered approach. Prehabilitation programs illustrate the benefits of an integrated strategy, whereas pharmacological approaches remain limited to date. Thus, sarcopenia should be considered an essential component of the care pathway in gastrointestinal oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Département de médecine, service d'oncologie digestive, Gustave-Roussy, 114, rue Édouard-Vaillant, 94800 Villejuif, France. Electronic address: geraldine.camilleri@gustaveroussy.fr.
- Service d'hépato-gastro-entérologie, Ambroise-Paré, 9, avenue Charles-de-Gaulle, 92100 Boulogne-Billancourt, France.
- Département de radiologie, hôpital Henri-Mondor, université Paris-Est, UPEC, Créteil, France.
- Laboratoire de physiologie de l'exercice, institut Strauss, Strasbourg, France; UR 3072 « Mitochondrie, stress oxydant et plasticité musculaire », Centre de recherche en biomédecine de Strasbourg (CRBS), université de S…
- Département prévention cancer environnement, centre Léon-Bérard, 28, rue Laënnec, 69008 Lyon, France.
- Département d'oncologie médicale, institut Curie, oncologie digestive, 35, rue Dailly, 92210 Saint-Cloud, France.
Zitieren
APA
Camilleri, G. M., Janvier, E., Pigneur, F., Mallard, J., Marijnen, P., Vidican, P., Mouret-Bonzi, M., Beltran, E. E. M., Cotard, O., Raynard, B., & Neuzillet, C. (2026). Sarcopénie en oncologie digestive : critères diagnostiques, implications cliniques et prise en charge. Bulletin du Cancer, 113(11), 1278-1292. https://doi.org/10.1016/j.bulcan.2026.06.005
Vancouver
Camilleri GM, Janvier E, Pigneur F, Mallard J, Marijnen P, Vidican P, et al. Sarcopénie en oncologie digestive : critères diagnostiques, implications cliniques et prise en charge. Bulletin du Cancer. 2026;113(11):1278-1292. doi:10.1016/j.bulcan.2026.06.005
BibTeX
@article{Camilleri2026,
author = {Camilleri, Géraldine M and Janvier, Eléa and Pigneur, Frédéric and Mallard, Joris and Marijnen, Philippe and Vidican, Pauline and Mouret-Bonzi, Mirianna and Beltran, Eva Esther Molina and Cotard, Océane and Raynard, Bruno and Neuzillet, Cindy},
title = {Sarcopénie en oncologie digestive : critères diagnostiques, implications cliniques et prise en charge},
journal = {Bulletin du Cancer},
year = {2026},
volume = {113},
number = {11},
pages = {1278--1292},
doi = {10.1016/j.bulcan.2026.06.005}
}
EUVIMED